Executive Committee: Syncona Limited

Manager
Positions heldSince
Annabel Clark

Annabel Clark

Investor Relations Contact 2018-04-30

Composition of the Board of Directors: Syncona Limited

Director
CommitteesSince
Melanie Gee

Melanie Gee

63 year

Compensation Committee 2019-06-03
Governance Committee Chair 2019-06-03
Nominating Committee Chair 2019-06-03
Virginia Holmes

Virginia Holmes

64 year

Governance Committee 2020-12-31
Nominating Committee 2020-12-31
Compensation Committee Chair 2017-03-30
Audit Committee 2020-12-31
Compensation Committee 2020-12-31
Robert A. Hutchinson

Robert A. Hutchinson

Compensation Committee 2018-10-31
Governance Committee 2017-10-31
Nominating Committee 2018-10-31
Audit Committee Chair 2018-03-31
Audit Committee 2018-10-31
Gian Reverberi

Gian Reverberi

58 year

Audit Committee 2018-03-31
Governance Committee 2018-03-31
Nominating Committee 2018-03-31
Compensation Committee Chair 2021-12-31
Julie Cherrington

Julie Cherrington

66 year

Audit Committee 2022-01-31
Governance Committee 2024-03-03
Nominating Committee 2024-03-03
Kemal Malik

Kemal Malik

62 year

Audit Committee 2020-06-14
Governance Committee 2020-06-14
Nominating Committee 2020-06-14
Cristina Csimma

Cristina Csimma

65 year

Compensation Committee 2022-01-31

Former Officers and Directors: Syncona Limited

Insider
Positions held
SinceUntil
Ken Galbraith
Ken Galbraith
Corporate Officer/Principal 2021-03-31 2021-12-31
Nicholas David Moss
Nicholas David Moss
Director/Board Member 2012-08-16 2021-12-30
Independent Dir/Board Member 2012-08-16 2021-12-30
Nigel Keen
Nigel Keen
Director/Board Member 2016-12-18 2021-12-30
Markus John
Markus John
Chief Tech/Sci/R&D Officer 2021-06-30 -
Siobhan Weaver
Siobhan Weaver
Investor Relations Contact - 2021-06-30
Public Communications Contact - 2021-06-30
Ellen Strahlman
Ellen Strahlman
Director/Board Member 2016-12-18 2020-11-01
Jeremy Tigue
Jeremy Tigue
Chairman 2012-08-13 2019-12-30
Independent Dir/Board Member 2012-08-13 2019-12-30
Iraj Ali
Iraj Ali
Corporate Officer/Principal 2016-11-30 2018-11-30
Arabella Cecil
Arabella Cecil
Director/Board Member 2015-09-08 2018-03-31
Chief Investment Officer 2015-09-08 2018-03-31
Founder 2015-09-08 2018-03-31
Anne Prener
Anne Prener
Chief Executive Officer 2017-11-21 -
Robert Coutts
Robert Coutts
Comptroller/Controller/Auditor 2015-05-31 2017-10-31
Peter Hames
Peter Hames
Director/Board Member - 2017-09-07
Independent Dir/Board Member - 2017-09-07
Sonia Bracegirdle
Sonia Bracegirdle
Corporate Officer/Principal - 2016-12-31
Colin C. Maltby
Colin C. Maltby
Director/Board Member - 2016-07-30
Independent Dir/Board Member - 2016-07-30
Martin Nicholas Caleb Thomas
Martin Nicholas Caleb Thomas
Director/Board Member - 2016-03-17
Independent Dir/Board Member - 2015-07-09
Jonathan Moulton
Jonathan Moulton
Director/Board Member - 2015-09-08
Independent Dir/Board Member - 2015-09-08
Thomas Alexander Gavin Henderson
Thomas Alexander Gavin Henderson
Director/Board Member 2012-08-13 -
Founder 2012-08-13 -
Martin Murphy
Martin Murphy
Chief Executive Officer - -
Chris Hollowood
Chris Hollowood
Corporate Officer/Principal - -
Chief Investment Officer - -

Age distribution of managers

Parity Men Women

Male 6
Female 3

Of which Executive Committee

Male 0
Female 1

Of which Directors

Male 5
Female 2
ESG Refinitiv
C+

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy
Logo Syncona Limited
Syncona Limited is a Guernsey-based closed-ended investment company. The Company’s investment objective is to achieve superior long-term capital appreciation from its investments. It seeks to achieve returns over the long term. It focuses on creating, building and scaling companies around science to create a diversified portfolio of 20-25 global healthcare businesses, across development stage and therapeutic areas. It focuses on developing treatments for patients by working in close partnership with academic founders and management teams. The Company makes its life science investments through Syncona Holdings Limited, a subsidiary of the Company. It maintains its capital pool through Syncona Investments LP Incorporated (the Partnership) in which the Company is the sole limited partner. The general partner of the Partnership is Syncona GP Limited (the General Partner), a wholly owned subsidiary of the Company. Syncona Investment Management Limited is its alternative investment manager.
Employees
1,050
Calendar
More about the company

Departures of Key Persons

Martin Murphy
-
Martin Murphy

Chief Executive Officer

Anne Prener
-
Anne Prener

Chief Executive Officer

2017-11-21 -

Jeremy Tigue
-
Jeremy Tigue

Chairman

2012-08-13 2019-12-30